25 Active TrialsInfusion CenterVirtual CareEst. 1997Large Center
9 MS centers statewide · Ranked #1 in Colorado for clinical trials · #1 in Colorado for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site
You are seen at an academic MS center that brings together neurology, therapy, and other specialty care in one place. You may appreciate the on-site infusion services, diagnostic testing, bilingual care options, and education programs designed to support day-to-day living with MS. You should know this is a large, regional center, so visits may feel more structured than at a small private practice.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research3/5
Insurance & Navigation Help4/5
Scheduling & Virtual Care4/5
About Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus
This center combines MS care with an academic medical setting and strong ties to the University of Colorado and UCHealth. It also stands out for its broad mix of specialty services, including neuro-opthalmology, neuro-radiology, neuro-urology, and behavioral neurology.
Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus provides care for multiple sclerosis, pediatric-onset MS, and other autoimmune neurological conditions. The team offers neurology care, infusion services, diagnostic testing, and symptom management with help from multiple specialties such as neuro-urology, neuro-otology, speech pathology, physical therapy, and behavioral neurology. Patients also have access to education programs, webinars, hydrotherapy, online exercise classes, and counseling support. Care is available in English and Spanish, and the center accepts most insurance plans.
Good to know
- Founded in 1997 and part of the University of Colorado Anschutz Medical Campus.
- On-site infusion services are available for patients who need them.
- Care is offered in both English and Spanish.
- Hydrotherapy classes are available at no cost except for a minimal pool fee.
- Virtual counseling sessions are offered at no cost.
Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus is an academic MS center in Aurora that has been serving patients since 1997. It is closely affiliated with the University of Colorado School of Medicine, UCHealth, and University of Colorado Hospital. You can expect care from a large, multidisciplinary team that includes neurologists, therapists, and other specialists. The center also offers on-site infusion services, diagnostic testing, education programs, and support services.
Featured Care Team Members
Dr. Enrique Alvarez
Vice Chair of Clinical Research and Professor
neurology
Dr. Jeffrey Bennett
Professor
neurology and ophthalmology
Dr. Robert Gross
Assistant Professor; Associate Program Director of Neuroimmunology/MS Fellowship
neurology
Dr. Ryan Kammeyer
Assistant Professor
pediatrics and neurology
Rachel Musenero, RN
Registered Nurse
multiple sclerosis care
Dr. Amanda Piquet
Director, Autoimmune Neurology Program
neurology
Dr. Teri Schreiner
Assistant Professor
neurology
Enrique Alvarez, MD, PhD
Active MS Prescriber
John Corboy, MD
Active MS Prescriber
Robert Gross, M.D.
Active MS Prescriber
Ryan Kammeyer, MD
Active MS Prescriber
Teri Schreiner, MD
Active MS Prescriber
Anna Shah, MD
Active MS Prescriber
Specialized Programs
hydrotherapy
online exercise classes
counseling services
MS 101
education summits
webinars
MS Young Professionals Network (MSYPN)
Conectar
King Adult Day Enrichment Program
Partnerships & Referral Network
- University of Colorado School of Medicine (teaching and research)
- UCHealth and University of Colorado Hospital (clinical and research teams)
- Children's Hospital Colorado (local patient care)
- Denver VA Medical Center (local patient care)
- Denver Health (local patient care)
Services & Treatments
What They Treat
multiple sclerosispediatric-onset multiple sclerosisautoimmune neurological diseasesautoimmune encephalitis
How They Treat It
neurology caremultiple sclerosis carestate-of-the-art diagnostic servicestreatmentmultidisciplinary symptom managementclinical researcheducation programssupport servicesinfusion servicesneuro-opthalmologyneuro-radiologyneuro-urologyneuro-otologyspeech pathologyphysical therapybehavioral neurologyinfusion serviceshydrotherapyadaptive exercisecounselingphysical therapyspeech pathology
Diagnostics
3.0 Tesla MRI scannerslaboratory testingdiagnostic servicestesting for disorders that mimic MS
Research & Clinical Trials
This center is currently involved in 25 clinical trials — ranked #1 in Colorado for active trials
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Kyverna Therapeutics
RECRUITING
KYV-101
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE2
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
RECRUITINGPHASE1
CC-97540FludarabineCyclophosphamide
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
ACTIVE NOT RECRUITINGPHASE3
TolebrutinibPlaceboTeriflunomide
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE3
Autologous Hematopoietic Stem Cell TransplantationBest Available Therapy (BAT)
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
ACTIVE NOT RECRUITING
Care in Multiple Sclerosis (MS)
NYU Langone Health
RECRUITING
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
The Cleveland Clinic
ACTIVE NOT RECRUITING
MRI
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
Ofatunumab
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
The Cleveland Clinic
ACTIVE NOT RECRUITINGPHASE4
Early Highly Effective Therapies GroupEscalation Therapies Group
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Ofatumumab approved doseOfatumumab new dose
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Biogen
RECRUITING
Diroximel FumarateAvonexTysabriDimethyl Fumarate
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
University of Colorado, Denver
RECRUITINGPHASE4
Ozanimod
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience Inc
RECRUITINGPHASE2
RE104 for Injection
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
University of Colorado, Boulder
RECRUITINGNA
Transcutaneous electrical nerve stimulation
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
everolimus
Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery
University of Colorado, Denver
RECRUITINGNA
Closed Loop Trans-Auricular Vagus Nerve Stimulation SystemPlacebo
Insurance & Access
Insurance & Support
English, Spanish
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus
Yes. The center has on-site infusion services for patients who need infusion-based treatment.
In addition to multiple sclerosis, the team also treats pediatric-onset multiple sclerosis, autoimmune neurological diseases, and autoimmune encephalitis.
You can access care from specialists in neuro-opthalmology, neuro-radiology, neuro-urology, neuro-otology, speech pathology, physical therapy, and behavioral neurology.
Yes. Programs include MS 101, education summits, webinars, hydrotherapy, online exercise classes, counseling, Conectar, and the MS Young Professionals Network.
Care is available in English and Spanish, which can help more patients feel comfortable getting support and information in the language they prefer.
Compare Colorado MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus Aurora | Academic MS Center | ✓ | ✓ | 3.6/5 |
Advanced Neurology of Colorado Fort Collins | Regional Neurology Group | — | — | 4.2/5 |
Rocky Mountain Multiple Sclerosis Center Westminster | Academic MS Center | — | — | 3.4/5 |
| Academic MS Center | — | — | 3.4/5 | |
UCHealth Neurology Fort Collins Fort Collins | Regional Neurology Group | — | — | 3/5 |
| Regional Neurology Group | — | — | 2.4/5 |
Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus
Aurora • Academic MS Center
Infusion
✓
Virtual
✓
Experience
3.6/5
Advanced Neurology of Colorado
Fort Collins • Regional Neurology Group
Infusion
—
Virtual
—
Experience
4.2/5
Rocky Mountain Multiple Sclerosis Center
Westminster • Academic MS Center
Infusion
—
Virtual
—
Experience
3.4/5
Children's Hospital Colorado
Aurora • Academic MS Center
Infusion
—
Virtual
—
Experience
3.4/5
UCHealth Neurology Fort Collins
Fort Collins • Regional Neurology Group
Infusion
—
Virtual
—
Experience
3/5
Denver Neurological Clinic
Denver • Regional Neurology Group
Infusion
—
Virtual
—
Experience
2.4/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.